These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8768003)

  • 1. [Modern strategies in therapy of acute myeloid leukemia (AML) in adulthood. I. Primary treatment of de novo AML].
    Jehn U; Dengler R; Petrides PE
    Internist (Berl); 1996 Jun; 37(6):661-8. PubMed ID: 8768003
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
    Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current situation and perspective for treatment of acute myelogenous leukemia in adults].
    Fukushima T; Ueda T
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute myeloid leukemia].
    Büchner T
    Internist (Berl); 1993 Jun; 34(6):511-7. PubMed ID: 8335440
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complications associated with short-term intensive consolidation chemotherapy for adults with acute myelogenous leukemia].
    Nagata K; Abe Y; Hatanaka T; Ito T; Saito M; Ono Y; Kamiya O; Ohara K
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1869-72. PubMed ID: 8379681
    [No Abstract]   [Full Text] [Related]  

  • 6. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.
    Wells RJ; Adams MT; Alonzo TA; Arceci RJ; Buckley J; Buxton AB; Dusenbery K; Gamis A; Masterson M; Vik T; Warkentin P; Whitlock JA;
    J Clin Oncol; 2003 Aug; 21(15):2940-7. PubMed ID: 12885813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Five cases of de novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) achieved CR with the continuous drip infusion of low-dose etoposide and low-dose cytosine arabinoside combined with mitoxantrone (MEtA)].
    Tsukaguchi M; Furukawa Y; Shibano M; Kitani T
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1119-23. PubMed ID: 15272598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.
    Liu J; Mi Y; Fu M; Yu W; Wang Y; Lin D; Bian S; Wang J
    Am J Hematol; 2009 Jul; 84(7):422-7. PubMed ID: 19484734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toxicity of different treatment protocols for acute myeloid leukemias in adults: the results of four Russian multicenter studies].
    Parovichnikova EN; Savchenko VG; Kliasova GA; Isaev VG; Sokolov AN; Kulikov SM; Ustinova EN; Gribanova EO; Ryzhko VV; Khoroshko ND; Kravchenko SK; Galstian GM; Konstantinova TS; Zagoskina TP; Ziuzgin IS; Kaplanov KD; Moskov VI; Sokolova IV; Anchukova LV; Lapin VA; Loginov AB; Tumakov VA; Korobkin AV; Miliutina GI; Samoĭlova OS; Tikunova TS; Pristupa AS; Kondakova EV; Domnikova NP; Gavrilova LV; Obidina NA; Porokhina OV; Rekhtman GB; Mashchuk VN; Khuazheva NK; Kaporskaia TS; Golubeva ME; Maksimov AG; Ploskikh MA; Men'shakova SN; Mal'tsev VI; Rossiev VA; Pilipenko GI
    Ter Arkh; 2010; 82(7):5-11. PubMed ID: 20853602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
    Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
    Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA.
    Suciu S; Solbu G; Zittoun R; Hayat M; Willemze R; de Witte T; Mandelli F
    Bone Marrow Transplant; 1991; 7 Suppl 2():34. PubMed ID: 1878707
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of acute leukemia in adults].
    Lechner K
    Wien Med Wochenschr; 1991; 141(9-10):180-90. PubMed ID: 1949839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity.
    Marcucci G; Stock W; Dai G; Klisovic RB; Liu S; Klisovic MI; Blum W; Kefauver C; Sher DA; Green M; Moran M; Maharry K; Novick S; Bloomfield CD; Zwiebel JA; Larson RA; Grever MR; Chan KK; Byrd JC
    J Clin Oncol; 2005 May; 23(15):3404-11. PubMed ID: 15824414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current therapeutic strategies in the management of acute myeloid leukemia].
    Fiegl M; Hiddemann W; Braess J
    Med Klin (Munich); 2007 Apr; 102(4):309-16. PubMed ID: 17426934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of cultured bone marrow cells for autologous transplantation in patients with acute myeloblastic leukemia.
    Testa NG; Coutinho L; Chang J; Morgenstern G; Scarffe JH; Dexter TM
    Haematol Blood Transfus; 1987; 31():75-8. PubMed ID: 3327789
    [No Abstract]   [Full Text] [Related]  

  • 16. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A network meta-analysis of randomized controlled trials of induction treatments in acute myeloid leukemia in the elderly.
    Ziogas DC; Voulgarelis M; Zintzaras E
    Clin Ther; 2011 Mar; 33(3):254-79. PubMed ID: 21600383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for adult acute myeloid leukemia: where we stand in 1995.
    Wiernik PH
    Acta Haematol Pol; 1995; 26(3):231-7. PubMed ID: 8525767
    [No Abstract]   [Full Text] [Related]  

  • 19. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy.
    Mattiuzzi GN; Kantarjian H; Faderl S; Lim J; Kontoyiannis D; Thomas D; Wierda W; Raad I; Garcia-Manero G; Zhou X; Ferrajoli A; Bekele N; Estey E
    Cancer; 2004 Feb; 100(3):581-9. PubMed ID: 14745876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.